Sodium Sulfacetamide 9% and Sulfur 4.5% Suspension

Rx Only

DESCRIPTION

Sodium Sulfacetamide is a sulfonamide with antibacterial with antibacterial activity while sulfur acts as a keratolytic agent. Chemically, Sodium Sulfacetamide is N-[(4-aminophenyl) sulfony]-acetamide, monosodium salt, monohydrate. The structural formula is:

Chemical Structure

Each mL of Sodium Sulfacetamide 9% & Sulfur 4.5% Suspension contains 90 mg of sodium sulfacetamide and 45 mg of sulfur in a formulation consisting of: aloe vera, fragrance, butylated hydroxytoluene, cetyl alcohol, disodium EDTA, disodium oleamido MEA sulfosuccinate, glyceryl stearate (and) PEG-100 stearate, green tea extract, magnesium aluminum silicate, methylparaben, propylparaben, purified water, sodium cocoyl isethionate, sodium methyl cocoyl tau rate, sodium thiosulfate, stearyl alcohol, and xanthan gum.

CLINICAL PHARMACOLOGY

The most widely accepted mechanism of action of sulfonamides in the Woods-Fildes theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, Sodium Sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

Zma Clear™ (Sodium Sulfacetamide 9% & Sulfur 4.5% Suspension) is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS

Zma Clear™ Sodium Sulfacetamide 9% & Sulfur 4.5% suspension is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur, or any other component of this preparation. Zma Clear™ is not to be used by patients with kidney disease.

WARNINGS

Although rare, sensitivity to Sodium Sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children. Keep container tightly closed.

Pediatric Use

Safety and effectiveness in children under the age of 12 has not been established.

ADVERSE REACTIONS

Although rare, sodium sulfacetamide may cause local irritation.

DOSAGE AND ADMINISTRATION

Apply Sodium Sulfacetamide 9% & Sulfur 4.5% Suspension once or twice daily to affected areas or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a lather. Rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 9% & Sulfur 4.5% Suspension sooner or using less often.

HOW SUPPLIED

Zma Clear™ Sodium Sulfacetamide 9% & Sulfur 4.5% suspension is available in an 8 oz (237 mL) bottle, NDC 82429-106-08.

STORAGE

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F).  Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F), however such exposure should be minimized.  Protect from freezing.

KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN

Manufactured by:

Gabar Health Sciences, Corp.
Atlanta, Georgia 30354

NDC 82429-106-08

Rx only

For topical use only

Not ophthalmic use

Sodium Sulfacetamide 9% & Sulfur 4.5% Suspension

Gabar Health Sciences Corp.

Net WT. 8oz. (237 mL)